Offer - Urjas Oil for just ₹ 1 X
Monocef O CV 200/125 Tablet (10) is a prescription medicine that is available as a Tablet. Monocef O CV 200/125 Tablet (10) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Monocef O CV 200/125 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Monocef O CV 200/125 Tablet (10) can also lead to other problems, which have been listed below. Such side effects of Monocef O CV 200/125 Tablet (10) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Monocef O CV 200/125 Tablet (10) has a Mild effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Monocef O CV 200/125 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Monocef O CV 200/125 Tablet (10) related warnings section.
Monocef O CV 200/125 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Monocef O CV 200/125 Tablet (10) in conditions like Jaundice. The section on Monocef O CV 200/125 Tablet (10) contraindications lists all such conditions.
Drug interactions for Monocef O CV 200/125 Tablet (10) have been reported in the medical literature. See below for a complete list.
You should also be aware that Monocef O CV 200/125 Tablet (10) is safe while driving, and is addiction.
Monocef O CV 200/125 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Monocef O CV 200/125 Tablet (10) safe for pregnant women?
Monocef O CV rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Monocef O CV 200/125 Tablet (10) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Monocef O CV. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Monocef O CV 200/125 Tablet (10) on the Kidneys?
There can be some harmful effects on your kidneys after taking Monocef O CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Monocef O CV 200/125 Tablet (10) on the Liver?
Monocef O CV may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Monocef O CV 200/125 Tablet (10) on the Heart?
Monocef O CV has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Monocef O CV 200/125 Tablet (10) unless your doctor advises you to do so -
Is this Monocef O CV 200/125 Tablet (10) habit forming or addictive?
No, you will not get addicted to Monocef O CV 200/125 Tablet (10).
Interaction between Food and Monocef O CV 200/125 Tablet (10)
Taking Monocef O CV 200/125 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Monocef O CV 200/125 Tablet (10)
It is difficult to say anything about the effect of Monocef O CV 200/125 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311